The chemical induction of synaesthesia
Surveying recreational users and developmental synaesthetes for 28 psychoactive drugs, the study found that serotonergic compounds—especially tryptamines and LSD—most frequently induce synaesthesia (commonly sound–colour), with induction rates clustering by drug class and similar patterns in controls and synaesthetes. The results support a serotonergic contribution to chemically induced synaesthesia, while also indicating individual susceptibility and possible involvement of non-serotonergic pathways.
Authors
- David Luke
- Devin Terhune
Published
Abstract
Objective
Preliminary research suggests that experiences resembling synaesthesia are frequently reported under the influence of a diverse range of chemical substances although the incidence, chemical specificity, and characteristics of these effects are poorly understood.
Methods
Here we surveyed recreational drug users and self-reported developmental synaesthetes regarding their use of 28 psychoactive drugs comprising 12 different drug classes and whether they had experienced synaesthesia under the influence of these substances.
Results
The drug class tryptamines exhibited the highest incidence rates of drug-induced synaesthesia in controls and induction rates of novel forms of synaesthesia in developmental synaesthetes. Induction incidence rates in controls were strongly correlated with the corresponding induction and enhancement rates in developmental synaesthetes. In addition, the use of LSD was the strongest predictor of drug-induced synaesthesia in both controls and developmental synaesthetes. Clear evidence was observed for a clustering of synaesthesia-induction rates as a function of drug class in both groups, denoting non-random incidence rates within drug classes. Sound-colour synaesthesia was the most commonly observed type of induced synaesthesia. Further analyses suggest the presence of synaesthesia-prone individuals, who were more likely to experience drug-induced synaesthesia with multiple drugs.
Conclusions
These data corroborate the hypothesized link between drug-induced synaesthesia and serotoninergic activity, but also suggest the possibility of alternative neurochemical pathways involved in the induction of synaesthesia. They further suggest that the induction and modulation of synaesthesia in controls and developmental synaesthetes share overlapping mechanisms and that certain individuals may be more susceptible to experiencing induced synaesthesia with different drugs.
Research Summary of 'The chemical induction of synaesthesia'
Introduction
Synaesthesia is a neurodevelopmental condition in which ordinary stimuli (inducers) evoke atypical, involuntary secondary experiences (concurrents), occurring in about 1–4% of the population. Previous work indicates a genetic basis with early environmental shaping of specific inducer-concurrent pairings, and reports exist of adult-onset synaesthesia following stroke, trauma or drug use. A contentious question addressed in the literature is whether synaesthesia-like experiences can be induced in non-synaesthetes; prior studies have shown that cognitive training, suggestion and several classic psychedelics can produce transient synaesthesia-like phenomena, with serotonin (5-HT2A) signalling implicated as a likely neurochemical mechanism. However, most pharmacological work has focused on serotonergic compounds, leaving open whether other neurochemical systems contribute, whether certain individuals are generally prone to chemically induced synaesthesia, and how recreational drugs modulate developmental synaesthesia. Luke and colleagues therefore conducted a broad survey of recreational drug users and self‑reported developmental synaesthetes to characterise the frequency, drug- and class-specificity, and phenomenology of drug-induced synaesthesia. The primary aims were to (1) estimate incidence rates of drug-induced synaesthesia across a larger set of commonly used psychoactive substances, (2) test whether induction clusters by drug class (suggesting neurochemical specificity), (3) describe the types of induced synaesthesia, and (4) examine how drugs affect existing developmental synaesthesias and whether some individuals are particularly prone to induction across drugs. The study used an online questionnaire to gather lifetime drug-use histories and self-reports of synaesthetic experiences under the influence.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Luke, D., Lungu, L., Friday, R., & Terhune, D. B. (2021). The chemical induction of synaesthesia. https://doi.org/10.31234/osf.io/s6eh3
References (12)
Papers cited by this study that are also in Blossom
Araújo, A. M., Carvalho, F. M., Carvalho, M. et al. · Archives of Toxicology (2015)
Barrett, F. S., Krimmel, S. R., Griffiths, R. R. et al. · NeuroImage (2020)
Brogaard, B. · Frontiers in Human Neuroscience (2013)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Kaelen, M., Roseman, L., Kahan, J. et al. · European Neuropsychopharmacology (2016)
Libânio Osório Marta, R. F. · Drug Metabolism Reviews (2019)
Luke, D. P., Terhune, D. B. · Frontiers in Psychology (2013)
Nichols, D. E. · Pharmacology and Therapeutics (2004)
Nichols, D. E. · Pharmacological Reviews (2016)
Sanz, C., Zamberlan, F., Erowid, E. et al. · Frontiers in Neuroscience (2018)
Show all 12 referencesShow fewer
Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)
Terhune, D. B., Luke, D. P., Kaelen, M. et al. · Neuropsychologia (2016)
Cited By (2)
Papers in Blossom that reference this study
Prugger, J., Hirschfeld, T., Majic, T. et al. · Neuropsychopharmacology (2023)
Michael, P., Luke, D., Robinson, O. · Frontiers in Psychology (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.